发明名称 Hydroxymorpholine derivatives
摘要 A compound of formula (I) <IMAGE> (I) or a pharmaceutically acceptable salt thereof, in which R1 is hydrogen, halogen, or trifluoromethyl; R2 is hydrogen or halogen; R3 is hydrogen or methyl; R4 is -O(CH2)a CO2H or an ester or amide derivative thereof, O(CH2)bM or -CO2H or an ester or amide derivative thereof wherein a is an integer from 1 to 6, b is an integer from 2 to 7, and M is hydroxy, C1-6 alkoxy or <IMAGE> wherein R6 and R7 are each hydrogen or C1-6 alkyl or <IMAGE> together form a five or six membered ring; R5 is C1-6 alkyl; C1-6 alkyl substituted by carboxy or esters and amides thereof; or phenyl optionally substituted by C1-6 alkyl, halogen, alkoxy or trifluoromethyl; R8 is hydrogen or C1-6 alkyl or R8 together with R5 form a carbocyclic ring; and n is 1 or 2. Processes for preparing these compounds and their use in therapy is also described.
申请公布号 US4596800(A) 申请公布日期 1986.06.24
申请号 US19850756795 申请日期 1985.07.19
申请人 BEECHAM GROUP P.L.C. 发明人 AINSWORTH, ANTHONY T.;HINDLEY, RICHARD M.
分类号 A61K31/535;A61K31/5375;A61K31/538;A61P3/08;C07C67/00;C07C213/00;C07C225/16;C07C227/00;C07C227/08;C07C229/22;C07C231/00;C07C231/12;C07C235/06;C07C235/20;C07C237/06;C07D265/32;C07D265/36;(IPC1-7):A61K31/535;C07D265/30 主分类号 A61K31/535
代理机构 代理人
主权项
地址